BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31555579)

  • 1. Comparison of Peri-operative and Early Oncological Outcomes of Robot-Assisted vs. Open Salvage Lymph Node Dissection in Recurrent Prostate Cancer.
    Devos G; Muilwijk T; Raskin Y; Calderon V; Moris L; Van den Broeck T; Berghen C; De Meerleer G; Albersen M; Van Poppel H; Everaerts W; Joniau S
    Front Oncol; 2019; 9():781. PubMed ID: 31555579
    [No Abstract]   [Full Text] [Related]  

  • 2. Robotic salvage lymph node dissection for nodal-only recurrences after radical prostatectomy: Perioperative and early oncological outcomes.
    Linxweiler J; Saar M; Al-Kailani Z; Janssen M; Ezziddin S; Stöckle M; Siemer S; Ohlmann CH
    Surg Oncol; 2018 Jun; 27(2):138-145. PubMed ID: 29937163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis.
    Kim KH; Lim SK; Kim HY; Shin TY; Lee JY; Choi YD; Chung BH; Hong SJ; Rha KH
    BJU Int; 2013 Jul; 112(2):216-23. PubMed ID: 23356436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological outcome of patients treated with spot-specific salvage lymphnode dissection (sLND) for positron-emission tomography (PET)-positive prostate cancer (PCa) relapse.
    Hiester A; Nini A; Niegisch G; Arsov C; Hautzel H; Antke C; Schimmöller L; Albers P; Rabenalt R
    World J Urol; 2019 Oct; 37(10):2081-2090. PubMed ID: 30643974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of salvage lymph node dissection in nonmetastatic castration-resistant prostate cancer: A single center experience.
    Boeri L; Sharma V; Nehra A; Kwon E; Karnes RJ
    Urol Oncol; 2020 Feb; 38(2):38.e9-38.e16. PubMed ID: 31653561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
    Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
    BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-term Outcomes Following Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Status Post-radical Prostatectomy.
    Zattoni F; Nehra A; Murphy CR; Rangel L; Mynderse L; Lowe V; Kwon E; Karnes RJ
    Eur Urol Focus; 2016 Dec; 2(5):522-531. PubMed ID: 28723518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy.
    Abdollah F; Briganti A; Montorsi F; Stenzl A; Stief C; Tombal B; Van Poppel H; Touijer K
    Eur Urol; 2015 May; 67(5):839-49. PubMed ID: 24698524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage pelvic lymph node dissection for lymph node recurrent prostate cancer.
    Rosiello G; Bandini M; Briganti A
    Curr Opin Urol; 2019 Nov; 29(6):629-635. PubMed ID: 31503189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study of the short-term efficacy and long-term efficacy of systematic lymph node dissection and elective lymph node dissection in patients with early esophageal cancer].
    Wu HR; Liu CQ; Guo MF; Mei XY; Tian JY; Xu MQ
    Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):706-711. PubMed ID: 30157578
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.
    Bochner BH; Dalbagni G; Sjoberg DD; Silberstein J; Keren Paz GE; Donat SM; Coleman JA; Mathew S; Vickers A; Schnorr GC; Feuerstein MA; Rapkin B; Parra RO; Herr HW; Laudone VP
    Eur Urol; 2015 Jun; 67(6):1042-1050. PubMed ID: 25496767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?
    Sivaraman A; Benfante N; Touijer K; Coleman J; Scardino P; Laudone V; Eastham J
    Investig Clin Urol; 2018 Mar; 59(2):83-90. PubMed ID: 29520383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review.
    Ploussard G; Gandaglia G; Borgmann H; de Visschere P; Heidegger I; Kretschmer A; Mathieu R; Surcel C; Tilki D; Tsaur I; Valerio M; van den Bergh R; Ost P; Briganti A;
    Eur Urol; 2019 Oct; 76(4):493-504. PubMed ID: 30391078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer.
    Gandaglia G; De Lorenzis E; Novara G; Fossati N; De Groote R; Dovey Z; Suardi N; Montorsi F; Briganti A; Rocco B; Mottrie A
    Eur Urol; 2017 Feb; 71(2):249-256. PubMed ID: 27209538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
    BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer.
    Bravi CA; Heidenreich A; Fossati N; Gandaglia G; Suardi N; Mazzone E; Stabile A; Cucchiara V; Osmonov D; Juenemann KP; Karnes RJ; Kretschmer A; Buchner A; Stief C; Hiester A; Albers P; Devos G; Joniau S; Van Poppel H; Grubmüller B; Shariat S; Tilki D; Graefen M; Gill IS; Mottrie A; Karakiewicz PI; Montorsi F; Briganti A; Pfister D
    BJUI Compass; 2023 Jan; 4(1):123-129. PubMed ID: 36569505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo neurogenic bladder dysfunction after salvage lymph node dissection in patients with nodal recurrence of prostate cancer.
    Hanske J; Müller G; van Ophoven A; von Landenberg N; Roghmann F; Palisaar RJ; von Bodman C; Noldus J; Brock M
    Neurourol Urodyn; 2018 Aug; 37(6):1988-1995. PubMed ID: 29504654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer.
    Porres D; Pfister D; Thissen A; Kuru TH; Zugor V; Buettner R; Knuechel R; Verburg FA; Heidenreich A
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):85-92. PubMed ID: 27824042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage lymph node dissection in hormone-naïve men: How effective is surgery?
    Hanske J; Ostholt J; Roghmann F; Müller G; Braun K; Gomez B; von Landenberg N; von Bodman C; Palisaar RJ; Liermann D; Noldus J; Brock M
    Urol Oncol; 2019 Nov; 37(11):812.e17-812.e24. PubMed ID: 31327750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy.
    Kenney PA; Nawaf CB; Mustafa M; Wen S; Wszolek MF; Pettaway CA; Ward JF; Davis JW; Pisters LL
    Can J Urol; 2016 Jun; 23(3):8271-7. PubMed ID: 27347619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.